Inventor · disambiguated record
Thierry Nivaggioli
Also filed as: NIVAGGIOLI THIERRY
48 granted patents·33 pending applications·954 citations·filing 1998–2025
99Inventor score
Top patents by PatentIndex Score
81 records- 0198US8512738B2Biodegradable intravitreal tyrosine kinase implantsEDELMAN JEFFREY L·Filed 2005·Granted Aug 20, 2013·89 cites·6 claims
- 0297US8409607B2Sustained release intraocular implants containing tyrosine kinase inhibitors and related methodsHUGHES PATRICK M·Filed 2008·Granted Apr 2, 2013·81 cites·8 claims
- 0397US8147865B2Steroid-containing sustained release intraocular implants and related methodsHUANG GLENN T·Filed 2006·Granted Apr 3, 2012·44 cites·15 claims
- 0497US8034370B2Ocular implant made by a double extrusion processALLERGAN INC·Filed 2007·Granted Oct 11, 2011·32 cites·8 claims
- 0597US8034366B2Ocular implant made by a double extrusion processALLERGAN INC·Filed 2007·Granted Oct 11, 2011·32 cites·9 claims
- 0696US8440216B2Sustained release intraocular implants and related methodsHUANG GLENN T·Filed 2012·Granted May 14, 2013·29 cites·7 claims
- 0796US8318070B2Ocular implant made by a double extrusion processSHIAH JANE-GUO·Filed 2011·Granted Nov 27, 2012·39 cites·5 claims
- 0895US8367097B2Liquid formulations for treatment of diseases or conditionsSANTEN PHARMACEUTICAL CO LTD·Filed 2010·Granted Feb 5, 2013·31 cites·14 claims
- 0995US7585517B2Transscleral deliveryMACUSIGHT INC·Filed 2004·Granted Sep 8, 2009·101 cites·31 claims
- 1094US10702539B2Ocular implant made by a double extrusion processALLERGAN INC·Filed 2018·Granted Jul 7, 2020·3 cites·19 claims
- 1194US9327059B2Steroid-containing sustained release intraocular implants and related methodsALLERGAN INC·Filed 2014·Granted May 3, 2016·8 cites·14 claims
- 1294US8968766B2Sustained release intraocular implants containing tyrosine kinase inhibitors and related methodsALLERGAN INC·Filed 2013·Granted Mar 3, 2015·19 cites·8 claims
- 1394US8927005B2Liquid formulations for treatment of diseases or conditionsSANTEN PHARMACEUTICAL CO LTD·Filed 2013·Granted Jan 6, 2015·20 cites·20 claims
- 1494US8119154B2Sustained release intraocular implants and related methodsHUANG GLENN T·Filed 2004·Granted Feb 21, 2012·41 cites·19 claims
- 1594US7771742B2Sustained release intraocular implants containing tyrosine kinase inhibitors and related methodsALLERGAN INC·Filed 2004·Granted Aug 10, 2010·47 cites·15 claims
- 1693US10874605B2Extended release biodegradable ocular implantsALLERGAN INC·Filed 2018·Granted Dec 29, 2020·7 cites·17 claims
- 1793US9192511B2Ocular implant made by a double extrusion processALLERGAN INC·Filed 2013·Granted Nov 24, 2015·10 cites·11 claims
- 1893US8048445B2Ocular implant made by a double extrusion processALLERGAN INC·Filed 2008·Granted Nov 1, 2011·14 cites·8 claims
- 1992US10076526B2Ocular implant made by a double extrusion processALLERGAN INC·Filed 2015·Granted Sep 18, 2018·6 cites·8 claims
- 2092US9233070B2Biodegradable intravitreal tyrosine kinase implantsALLERGAN INC·Filed 2013·Granted Jan 12, 2016·6 cites·5 claims
- 2192US8685435B2Extended release biodegradable ocular implantsNIVAGGIOLI THIERRY·Filed 2004·Granted Apr 1, 2014·48 cites·2 claims
- 2292US8263110B2Sustained release intraocular implants and related methodsHUANG GLENN T·Filed 2008·Granted Sep 11, 2012·13 cites·7 claims
- 2391US8506987B2Ocular implant made by a double extrusion processSHIAH JANE-GUO·Filed 2011·Granted Aug 13, 2013·12 cites·13 claims
- 2491US8486960B2Formulations and methods for vascular permeability-related diseases or conditionsKLEINMAN DAVID M·Filed 2012·Granted Jul 16, 2013·17 cites·9 claims
- 2591US8298570B2Sustained release intraocular implants and related methodsHUANG GLENN T·Filed 2008·Granted Oct 30, 2012·12 cites·10 claims
- 2691US8257730B2Steroid-containing sustained release intraocular implants and related methodsHUANG GLENN T·Filed 2005·Granted Sep 4, 2012·12 cites·11 claims
- 2790US8663639B2Formulations for treating ocular diseases and conditionsDOR PHILIPPE J M·Filed 2008·Granted Mar 4, 2014·37 cites·11 claims
- 2889US8771722B2Methods of treating ocular disease using steroid-containing sustained release intraocular implantsHUANG GLENN T·Filed 2012·Granted Jul 8, 2014·8 cites·10 claims
- 2988US2024238312A1Ocular implant made by a double extrusion processALLERGAN INC·Filed 2024·Application pending·0 cites
- 3087US10076492B2Biodegradable intravitreal tyrosine kinase implantsALLERGAN INC·Filed 2016·Granted Sep 18, 2018·4 cites·4 claims
- 3187US8962009B2Sustained release intraocular implants and related methodsHUANG GLENN T·Filed 2013·Granted Feb 24, 2015·6 cites·9 claims
- 3286US6635282B1Gellan gum tablet film coatingPHARMACIA CORP·Filed 2000·Granted Oct 21, 2003·13 cites·21 claims
- 3385US10881608B2Biodegradable intravitreal tyrosine kinase implantsALLERGAN INC·Filed 2018·Granted Jan 5, 2021·1 cites·7 claims
- 3484US6326028B1Alginate and gellan gum as tablet coatingMONSANTO CO·Filed 1998·Granted Dec 4, 2001·45 cites·6 claims
- 3583US9387165B2Rapamycin formulations and methods of their useSANTEN PHARMACEUTICAL CO LTD·Filed 2014·Granted Jul 12, 2016·3 cites·7 claims
- 3682US8974812B2Extended release biodegradable ocular implantsALLERGAN INC·Filed 2014·Granted Mar 10, 2015·3 cites·5 claims
- 3782US8637070B2Rapamycin formulations and methods of their useMUDUMBA SREENIVASU·Filed 2006·Granted Jan 28, 2014·4 cites·8 claims
- 3882US6395298B1Gellan gum tablet coatingPHARMACIA CORP·Filed 1998·Granted May 28, 2002·41 cites·14 claims
- 3981US8492400B2Stable formulations, and methods of their preparation and useMUDUMBA SREENIVASU·Filed 2007·Granted Jul 23, 2013·6 cites·26 claims
- 4081US2023172948A1Ocular implant made by a double extrusion procesALLERGAN INC·Filed 2022·Application pending·0 cites
- 4179US8404267B2Sustained release intraocular implants containing tyrosine kinase inhibitors and related methodsHUGHES PATRICK M·Filed 2008·Granted Mar 26, 2013·2 cites·3 claims
- 4279US8222271B2Formulations and methods for vascular permeability-related diseases or conditionsKLEINMAN DAVID M·Filed 2007·Granted Jul 17, 2012·3 cites·9 claims
- 4376US9381153B2Liquid formulations for treatment of diseases or conditionsSANTEN PHARMACEUTICAL CO LTD·Filed 2014·Granted Jul 5, 2016·1 cites·2 claims
- 4476US2021113592A1Ocular implant made by a double extrusion procesALLERGAN INC·Filed 2020·Application pending·0 cites
- 4575US8895049B2Extended release biodegradable ocular implantsALLERGAN INC·Filed 2013·Granted Nov 25, 2014·1 cites·5 claims
- 4674US8658667B2Stable formulations, and methods of their preparation and useSANTEN PHARMACEUTICAL CO LTD·Filed 2013·Granted Feb 25, 2014·2 cites·23 claims
- 4774US2008145407A1Methods for reducing neovascularization or edemaALLERGAN INC·Filed 2007·Application pending·0 cites
- 4874US2009163550A1Retinoid-containing sustained release intraocular implants and related methodsALLERGAN INC·Filed 2009·Application pending·0 cites
- 4973US2021121397A1Biodegradable intravitreal tyrosine kinase implantsALLERGAN INC·Filed 2021·Application pending·0 cites
- 5072US8715709B2Sustained release intraocular implants and methods for treating ocular neuropathiesHUANG GLENN T·Filed 2010·Granted May 6, 2014·1 cites·1 claims
Showing the top 50 of 81 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →